Ninlaro
(nin-LAR-oh)
A drug used with lenalidomide and dexamethasone to treat multiple myeloma. It is used in patients who received at least one other anticancer treatment. It is also being studied in the treatment of other types of cancer. Ninlaro blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called ixazomib citrate.